Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus

Authors

Sarah V. Maifeld, Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America.
Bodrey Ro, Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America.
Hoyin Mok, Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America.
Marla Chu, Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America.
Li Yu, Non-clinical Biostatistics, MedImmune, Gaithersburg, Maryland, United States of America.
Ryan Yamagata, Non-clinical Biostatistics, MedImmune, Gaithersburg, Maryland, United States of America.
Tansy Leonardson, Vaccine and Analytical Sciences, MedImmune, Mountain View, California, United States of America.
Vera Chio, Vaccine and Analytical Sciences, MedImmune, Mountain View, California, United States of America.
Bandita Parhy, Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America.
Samuel Park, Vaccine and Analytical Sciences, MedImmune, Mountain View, California, United States of America.
Marcia Carlson, Purification Process Sciences, MedImmune, Gaithersburg, Maryland, United States of America.
Shushil Machhi, Cell Culture and Fermentation Sciences, MedImmune, Gaithersburg, Maryland, United States of America.
Nancy Ulbrandt, Department of Infectious Disease and Vaccines, Gaithersburg, California, United States of America.
Ann R. Falsey, Rochester Regional HealthFollow
Edward E. Walsh, Rochester Regional HealthFollow
C Kathy Wang, Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America.
Mark T. Esser, Translational Medicine, MedImmune, Gaithersburg, Maryland, United States of America.
Fengrong Zuo, Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America.

Department

Medicine

Document Type

Article

Publication Title

PloS One

Abstract

Sensitive and precise serology assays are needed to measure the humoral response to antigens of respiratory syncytial virus (RSV) following natural infection or vaccination. We developed and evaluated a collection of electrochemiluminescent (ECL) serology assays using four RSV antigens (F, N, Ga and Gb). To assess the merits of ECL technology, the four ECL serology assays were evaluated using a well-characterized "gold standard" panel of acute and convalescent serum samples from fifty-nine RSV-positive and thirty RSV-negative elderly subjects (≥65 years old). The combined results from the four ECL assays demonstrated good concordance to the "gold standard" diagnosis, reaching 95% diagnostic sensitivity and 100% diagnostic specificity. Additionally, a combination of ECL assays provided higher diagnostic sensitivity than a commercially available diagnostic ELISA or cell-based microneutralization assay. In summary, these data demonstrate the advantages of using ECL-based serology assays and highlight their use as a sensitive diagnostic approach to detect recent RSV infection in an elderly population.

First Page

e0153019

DOI

10.1371/journal.pone.0153019

Volume

11

Issue

4

Publication Date

4-12-2016

Medical Subject Headings

Aged; Antibodies, Monoclonal, Humanized (immunology); Antibodies, Neutralizing (blood); Antibodies, Viral (blood); Antigens, Viral (immunology); Child, Preschool; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Infant; Luminescent Measurements (methods); Neutralization Tests; Nucleocapsid Proteins (immunology); Respiratory Syncytial Virus Infections (diagnosis, immunology); Respiratory Syncytial Virus, Human (immunology); Serologic Tests (methods); Viral Envelope Proteins (immunology); Viral Fusion Proteins (immunology)

PubMed ID

27070145

Share

COinS